By Reuters

Aug 23 (Reuters) - The U.S. Food and Drug Administration on Friday classified a recall of Inari Medical's (NARI.O), opens new tab ClotTriever catheter that helps capture and remove large clot from big vessels as "most serious".

The affected products include all devices and lot numbers with labeled dates prior to Aug. 1, 2024, whose use might cause serious adverse health consequences, including device entrapment, vessel damage, and/or blockage of lung arteries and death, the FDA said.

Advertisement · Scroll to continue

Report this ad

There have been four reported injuries and six reports of death, according to the statement, opens new tab by the health regulator.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Reporting by Savyata Mishra in Bengaluru; Editing by Arun Koyyur